Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimegepant for Acute Migraine
NCT03237845Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rimegepant in migraine, sponsored by Pfizer. Started Jul 2017; status: completed.
02
Drugs
rimegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03237845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03237845.